In the current critical review we discuss these emerging trends in localized and systemic treatment as well as possible interesting combinations of the two modalities. Finally, we discuss the role of the new systemic agents in non–clear cell RCC.
Waleed Fouad Mourad, MD, MS, PhD
Advertisement
Articles by Waleed Fouad Mourad, MD, MS, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Personalized Cancer Vaccine/Pembrolizumab Feasible, Effective in Newly Diagnosed GBM
2
SC Amivantamab May Provide More Convenience in CHRYSALIS-2 Regimen
3
RAMPART Trial Does Not Meet DFS End Point in RCC
4
Adjuvant Giredestrant Improves Invasive DFS in ER+, HER2– Early Breast Cancer
5